ALK Inhibition With Alectinib for Refractory Metastatic Renal Cell Carcinoma With ALK Rearrangement: A Rare Case Report and Literature Review

被引：0
|
作者：
Kathuria-Prakash, Nikhita [1 ]
Lopez, Lidia P. [1 ]
Raman, Steven [2 ]
Ye, Huihui [3 ]
Anaokar, Jordan [2 ]
Sisk, Anthony [4 ]
Pantuck, Allan J. [5 ]
Drakaki, Alexandra [1 ]
机构：
[1] Univ Calif Los Angeles, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Dept Radiol, Los Angeles, CA USA
[3] Cedars Sinai Med Ctr, Dept Pathol, Los Angeles, CA USA
[4] Univ Calif Los Angeles, Dept Pathol, Los Angeles, CA USA
[5] Univ Calif Los Angeles, Dept Urol, Los Angeles, CA USA
来源：
JCO PRECISION ONCOLOGY | 2024年 / 8卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：6
相关论文
共 50 条
  • [1] ALK Inhibition With Alectinib for Refractory Metastatic Renal Cell Carcinoma With ALK Rearrangement: A Rare Case Report and Literature Review
    Kathuria-Prakash, Nikhita
    Lopez, Lidia P.
    Raman, Steven
    Ye, Huihui
    Anaokar, Jordan
    Sisk, Anthony
    Pantuck, Allan J.
    Drakaki, Alexandra
    [J]. JCO PRECISION ONCOLOGY, 2024, 8
  • [2] ALK-TPM3 rearrangement in adult renal cell carcinoma: a case report and literature review
    Jing Yang
    Lei Dong
    Hong Du
    Xiu-bo Li
    Yan-xiao Liang
    Guo-rong Liu
    [J]. Diagnostic Pathology, 14
  • [3] ALK-TPM3 rearrangement in adult renal cell carcinoma: a case report and literature review
    Yang, Jing
    Dong, Lei
    Du, Hong
    Li, Xiu-bo
    Liang, Yan-xiao
    Liu, Guo-rong
    [J]. DIAGNOSTIC PATHOLOGY, 2019, 14 (01)
  • [4] Exceptional response to alectinib for duodenal carcinoma with ALK fusion: A case report and literature review
    Isaka, Yuri
    Sasaki, Akinori
    Saito, Akira
    Motomura, Yasuaki
    Ando, Yayoi
    Nakamura, Yoshiaki
    [J]. FRONTIERS IN ONCOLOGY, 2023, 12
  • [5] ALK-rearranged lung squamous cell carcinoma responding to alectinib: a case report and review of the literature
    Mamesaya, Nobuaki
    Nakashima, Kazuhisa
    Naito, Tateaki
    Nakajima, Takashi
    Endo, Masahiro
    Takahashi, Toshiaki
    [J]. BMC CANCER, 2017, 17
  • [6] ALK-rearranged lung squamous cell carcinoma responding to alectinib: a case report and review of the literature
    Nobuaki Mamesaya
    Kazuhisa Nakashima
    Tateaki Naito
    Takashi Nakajima
    Masahiro Endo
    Toshiaki Takahashi
    [J]. BMC Cancer, 17
  • [7] Combined small cell lung carcinoma harboring ALK rearrangement: A case report and literature review
    Niitsu, Takayuki
    Shiroyama, Takayuki
    Miyake, Kotaro
    Noda, Yoshimi
    Kido, Kansuke
    Hara, Reina
    Enomoto, Takatoshi
    Adachi, Yuichi
    Amiya, Saori
    Suga, Yasuhiko
    Fukushima, Kiyoharu
    Koyama, Shohei
    Iwahori, Kota
    Hirata, Haruhiko
    Nagatomo, Izumi
    Takeda, Yoshito
    Kumanogoh, Atsushi
    [J]. THORACIC CANCER, 2020, 11 (12) : 3625 - 3630
  • [8] Anaplastic lymphoma kinase (ALK) rearrangement in adult renal cell carcinoma with lung metastasis: a case report and literature review
    Zhou, Shengyu
    Sun, Guanxing
    Wang, Jianwei
    Zhang, Hongtu
    [J]. TRANSLATIONAL ANDROLOGY AND UROLOGY, 2020, 9 (06) : 2855 - 2861
  • [9] Clinical Responses to Crizotinib, Alectinib, and Lorlatinib in a Metastatic Colorectal Carcinoma Patient With ALK Gene Rearrangement: A Case Report
    He, Xi
    Jiao, Xiao-Dong
    Liu, Ke
    Qin, Bao-Dong
    Wu, Ying
    Ling, Yan
    Liu, Jun
    Xu, A-Qiao
    Song, Kun
    Zang, Yuan-Sheng
    [J]. JCO PRECISION ONCOLOGY, 2021, 5 : 771 - 778
  • [10] A Case of Squamous Cell Carcinoma Harboring an EML4-ALK Rearrangement that Was Unsuccessfully Treated with the ALK Inhibitor Alectinib
    Tamiya, Akihiro
    Shimizu, Shigeki
    Atagi, Shinji
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (08) : E74 - E75
12345